Shares in Senseonics (NYSE:SENS) fell today after the medical device maker missed EPS expectations but met sales estimates on Wall Street with its third quarter financial results.
The Germantown, Md.-based company posted a net loss of -$31.9 million on sales of $5.2 million for the 3 months ended Sept. 30. Quarterly net losses were up 83% on sales growth of 146% compared with the same period last year.
Get the full story at our sister site, Drug Delivery Business News.
The post Senseonics reports mixed Q3 results appeared first on MassDevice.
from MassDevice https://ift.tt/2OzIyQ1
Cap comentari:
Publica un comentari a l'entrada